Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration

Epidemiology

Volumn 18, Issue 6, 2007, Pages 805-835

  Vandenbroucke, Jan P ^a   Von Elm, Erik ^b,c   Altman, Douglas G ^d   Gøtzsche, Peter C ^e   Mulrow, Cynthia D ^f   Pocock, Stuart J ^g   Poole, Charles ^h   Schlesselman, James J ⁱ   Egger, Matthias ^b,j,k  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e Rigshospitalet   (Denmark)

^f UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^g LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^h IL   (United States)

ⁱ UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^j UNIVERSITY OF BRISTOL   (United Kingdom)

^k UNIVERSITY OF BERN   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DOCUMENTATION; EPIDEMIOLOGICAL DATA; MEDICAL LITERATURE; MEDICAL RESEARCH; METHODOLOGY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PUBLICATION; REVIEW;

EPIDEMIOLOGIC RESEARCH DESIGN; GUIDELINES AS TOPIC; OBSERVATION; PUBLISHING; UNITED STATES;

EID: 35649024173     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/EDE.0b013e3181577511     Document Type: Review

References (237)

1. Glasziou P, Vandenbroucke JP, Chalmers I. Assessing the quality of research. BMJ. 2004;328:39-41.
2. Funai EF, Rosenbush EJ, Lee MJ, Del Priore G. Distribution of study designs in four major US journals of obstetrics and gynecology. Gynecol Obstet Invest. 2001;51:8-11.
3. Scales CD Jr, Norris RD, Peterson BL, Preminger GM, Dahm P. Clinical research and statistical methods in the urology literature. J Urol. 2005;174:1374-9.
4. Pocock SJ, Collier TJ, Dandreo KJ, et al. Issues in the reporting of epidemiological studies: a survey of recent practice. BMJ. 2004;329:883.
5. Tooth L, Ware R, Bain C, Purdie DM, Dobson A. Quality of reporting of observational longitudinal research. American Journal of Epidemiology. 2005;161:280-8.
6. von Elm E, Altman D, Egger M, Pocock S, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Epidemiology. 2007;18:800-804.
7. Mihailovic A, Bell CM, Urbach DR. Users' guide to the surgical literature. Case-control studies in surgical journals. Can J Surg. 2005;48:148-51.
8. Rushton L. Reporting of occupational and environmental research: use and misuse of statistical and epidemiological methods. Occup Environ Med. 2000;57:1-9.
9. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1:43-6.
10. Moonesinghe R, Khoury MJ, Janssens AC. Most published research findings are false-but a little replication goes a long way. PLoS Medicine. 2007;4:e28.
11. Jenicek M. Clinical Case Reporting. Evidence-Based Medicine. Oxford: Butterworth-Heinemann; 1999; p. 117.
12. Vandenbroucke JP. In defense of case reports and case series. Annals of Internal Medicine. 2001;134:330-4.
13. Bossuyt PM, Reitsma JB, Bruns DE, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Annals of Internal Medicine. 2003;138:40-4.
14. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM. REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer. 2005;93:387-91.
15. Ioannidis JP, Gwinn M, Little J, et al. A road map for efficient and reliable human genome epidemiology. Nat Genet. 2006;38:3-5.
16. Rodrigues L, Kirkwood BR. Case-control designs in the study of common diseases: updates on the demise of the rare disease assumption and the choice of sampling scheme for controls. International Journal of Epidemiology. 1990;19:205-13.
17. Rothman KJ, Greenland S. Case-Control Studies. In: Rothman KJ, Greenland S, editors. Modern epidemiology. 2nd ed: Lippincott Raven; 1998. p. 93-114.
18. Forand SP. Leukaemia incidence among workers in the shoe and boot manufacturing industry: a case-control study. Environ Health. 2004;3:7
19. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. The New England Journal of Medicine. 2000;342:1878-86.
20. Gøtzsche PC, Harden A. Searching for non-randomised studies. Draft chapter 3. Cochrane Non-Randomised Studies Methods Group, 26 July 2002 (http://www.cochrane.dk/nrsmg).
21. Lohse N, Hansen AB, Pedersen G, et al. Survival of persons with and without HIV infection in Denmark, 1995-2005. Annals of Internal Medicine. 2007;146:87-95.
22. American Journal of Epidemiology. Instructions to authors. Available from: http://www.oxfordjournals.org/our_journals/aje/for_authors/ general.html.
23. Haynes RB, Mulrow CD, Huth EJ, Altman DG, Gardner MJ. More informative abstracts revisited. Annals of Internal Medicine. 1990;113:69-76.
24. Taddio A, Pain T, Fassos FF, Boon H, Ilersich AL, Einarson TR. Quality of nonstructured and structured abstracts of original research articles in the British Medical Journal, the Canadian Medical Association Journal and the Journal of the American Medical Association. Canadian Medical Association Journal. 1994;150:1611-5.
25. Hartley J, Sydes M. Which layout do you prefer? An analysis of readers' preferences for different typographic layouts of structured abstracts. Journal of Information Science. 1996;22:27-37.
26. Viner RM, Cole TJ. Adult socioeconomic, educational, social, and psychological outcomes of childhood obesity: a national birth cohort study. BMJ. 2005;330:1354.
27. McCauley J, Kern DE, Kolodner K, et al. The "battering syndrome": prevalence and clinical characteristics of domestic violence in primary care internal medicine practices. Annals of Internal Medicine. 1995;123:737-46.
28. McEvoy SP, Stevenson MR, McCartt AT, et al. Role of mobile phones in motor vehicle crashes resulting in hospital attendance: a case-crossover study. BMJ. 2005;331:428.
29. Vandenbroucke JP. Prospective or retrospective: what's in a name? BMJ. 1991;302:249-50.
30. Last JM. A Dictionary of Epidemiology. 4th ed. New York: Oxford University Press; 2000.
31. Miettinen OS. Theoretical Epidemiology: principles of occurrence research in medicine. New York: Wiley; 1985.
32. Rothman KJ, Greenland S. Types of Epidemiologic Studies. In: Rothman KJ, Greenland S, editors. Modern Epidemiology. 2nd ed: Lippincott Raven; 1998. p. 74-5.
33. MacMahon B, Trichopoulos D. Epidemiology, principles and methods. 2nd ed. Boston: Little, Brown and Co.; 1996. p. 81.
34. Lilienfeld AM. Foundations of Epidemiology. New York: Oxford University Press; 1976.
35. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. The New England Journal of Medicine. 1995;332:912-7.
36. Goodman KJ, O'Rourke K, Day RS, et al. Dynamics of Helicobacter pylori infection in a US-Mexico cohort during the first two years of life. International Journal of Epidemiology. 2005;34:1348-55.
37. Altman DG, De Stavola BL, Love SB, Stepniewska KA. Review of survival analyses published in cancer journals. Br J Cancer. 1995;72:511-8.
38. Cerhan JR, Wallace RB, Folsom AR, Potter JD, Munger RG, Prineas RJ. Transfusion history and cancer risk in older women. Annals of Internal Medicine. 1993;119:8-15.
39. Beane Freeman LE, Dennis LK, Lynch CF, Thorne PS, Just CL. Toenail arsenic content and cutaneous melanoma in Iowa. American Journal of Epidemiology. 2004;160:679-87.
40. Canto JG, Allison JJ, Kiefe CI, et al. Relation of race and sex to the use of reperfusion therapy in Medicare beneficiaries with acute myocardial infarction. The New England Journal of Medicine. 2000;342:1094-100.
41. Metzkor-Cotter E, Kletter Y, Avidor B, et al. Long-term serological analysis and clinical follow-up of patients with cat scratch disease. Clin Infect Dis. 2003;37:1149-54.
42. Johnson ES. Bias on withdrawing lost subjects from the analysis at the time of loss, in cohort mortality studies, and in follow-up methods. J Occup Med. 1990;32:250-4.
43. Berkson J. Limitations of the application of fourfold table analysis to hospital data. Biometrics Bulletin 1946;2:53.
44. Feinstein AR, Walter SD, Horwitz RI. An analysis of Berkson's bias in case-control studies. J Chronic Dis. 1986;39:495-504.
45. Jick H, Vessey MP. Case-control studies in the evaluation of drug-induced illness. American Journal of Epidemiology. 1978;107:1-7.
46. Hackam DG, Mamdani M, Li P, Redelmeier DA. Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis. Lancet. 2006;367:413-8.
47. Smeeth L, Cook C, Fombonne E, et al. MMR vaccination and pervasive developmental disorders: a case-control study. Lancet. 2004;364:963-9.
48. Costanza MC. Matching. Prev Med. 1995;24:425-33.
49. Sturmer T, Brenner H. Flexible matching strategies to increase power and efficiency to detect and estimate gene-environment interactions in case-control studies. American Journal of Epidemiology. 2002;155:593-602.
50. Rothman KJ, Greenland S. Matching. In: Rothman KJ, Greenland S, editors. Modern Epidemiology. 2nd ed: Lippincott Raven; 1998. p. 147-61.
51. Szklo MF, Nieto J. Epidemiology, Beyond the Basics. Sudbury, MA: Jones and Bartlett; 2000. p. 40-51.
52. Cole P, MacMahon B. Attributable risk percent in case-control studies. Br J Prev Soc Med. 1971;25:242-4.
53. Gissler M, Hemminki E. The danger of overmatching in studies of the perinatal mortality and birthweight of infants born after assisted conception. Eur J Obstet Gynecol Reprod Biol. 1996;69:73-5.
54. Gefeller O, Pfahlberg A, Brenner H, Windeler J. An empirical investigation on matching in published case-control studies. Eur J Epidemiol. 1998;14:321-5.
55. Artama M, Ritvanen A, Gissler M, Isojarvi J, Auvinen A. Congenital structural anomalies in offspring of women with epilepsy-a population-based cohort study in Finland. International Journal of Epidemiology. 2006;35:280-7.
56. Ebrahim S. Cohorts, infants and children. International Journal of Epidemiology. 2004;33:1165-66.
57. Walker M, Whincup PH, Shaper AG. The British Regional Heart Study 1975-2004. International Journal of Epidemiology. 2004;33:1185-92.
58. Wieland S, Dickersin K. Selective exposure reporting and Medline indexing limited the search sensitivity for observational studies of the adverse effects of oral contraceptives. J Clin Epidemiol. 2005;58:560-7.
59. Anderson HR, Atkinson RW, Peacock JL, Sweeting MJ, Marston L. Ambient particulate matter and health effects: publication bias in studies of short-term associations. Epidemiology. 2005;16:155-63.
60. Winkelmayer WC, Stampfer MJ, Willett WC, Curhan GC. Habitual caffeine intake and the risk of hypertension in women. JAMA. 2005;294:2330-5.
61. Lukanova A, Soderberg S, Kaaks R, Jellum E, Stattin P. Serum adiponectin is not associated with risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2006;15:401-2.
62. Becher H. The concept of residual confounding in regression models and some applications. Stat Med. 1992;11:1747-58.
63. Brenner H, Blettner M. Controlling for continuous confounders in epidemiologic research. Epidemiology. 1997;8:429-34.
64. Phillips MR, Yang G, Zhang Y, Wang L, Ji H, Zhou M. Risk factors for suicide in China: a national case-control psychological autopsy study. Lancet. 2002;360:1728-36.
65. Pasquale LR, Kang JH, Manson JE, Willett WC, Rosner BA, Hankinson SE. Prospective study of type 2 diabetes mellitus and risk of primary open-angle glaucoma in women. Ophthalmology. 2006;113:1081-6.
66. Craig SL, Feinstein AR. Antecedent therapy versus detection bias as causes of neoplastic multimorbidity. Am J Clin Oncol. 1999;22:51-6.
67. Rogler LH, Mroczek DK, Fellows M, Loftus ST. The neglect of response bias in mental health research. J Nerv Ment Dis. 2001;189:182-7.
68. Murphy EA. The logic of medicine. Baltimore: Johns Hopkins University Press; 1976.
69. Sackett DL. Bias in analytic research. J Chronic Dis. 1979;32:51-63.
70. Johannes CB, Crawford SL, McKinlay JB. Interviewer effects in a cohort study. Results from the Massachusetts Women's Health Study. American Journal of Epidemiology. 1997;146:429-38.
71. Bloemenkamp KW, Rosendaal FR, Buller HR, Helmerhorst FM, Colly LP, Vandenbroucke JP. Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias. Arch Intern Med. 1999;159:65-70.
72. Feinstein AR. Clinical epidemiology: the architecture of clinical research. Philadelphia: W.B. Saunders Company; 1985.
73. Yadon ZE, Rodrigues LC, Davies CR, Quigley MA. Indoor and peridomestic transmission of American cutaneous leishmaniasis in northwestern Argentina: a retrospective case-control study. The American Journal of Tropical Medicine and Hygiene. 2003;68:519-26.
74. Anoop S, Saravanan B, Joseph A, Cherian A, Jacob KS. Maternal depression and low maternal intelligence as risk factors for malnutrition in children: a community based case-control study from South India. Arch Dis Child. 2004;89:325-9.
75. Carlin JB, Doyle LW. Sample size. J Paediatr Child Health. 2002;38:300-4.
76. Rigby AS, Vail A. Statistical methods in epidemiology. II: A common-sense approach to sample size estimation. Disabil Rehabil. 1998;20:405-10.
77. Schulz KF, Grimes DA. Sample size calculations in randomised trials: mandatory and mystical. Lancet. 2005;365:1348-53.
78. Drescher K, Timm J, Jockel KH. The design of case-control studies: the effect of confounding on sample size requirements. Stat Med. 1990;9:765-76.
79. Devine OJ, Smith JM. Estimating sample size for epidemiologic studies: the impact of ignoring exposure measurement uncertainty. Stat Med. 1998;17:1375-89.
80. Linn S, Levi L, Grunau PD, Zaidise I, Zarka S. Effect measure modification and confounding of severe head injury mortality by age and multiple organ injury severity. Annals of epidemiology. 2007;17:142-7.
81. Altman DG, Lausen B, Sauerbrei W, Schumacher M. Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst. 1994;86:829-35.
82. Royston P, Altman DG, Sauerbrei W. Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med. 2006;25:127-41.
83. Greenland S. Avoiding power loss associated with categorization and ordinal scores in dose-response and trend analysis. Epidemiology. 1995;6:450-4.
84. Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. International Journal of Epidemiology. 1999;28:964-74.
85. MacCallum RC, Zhang S, Preacher KJ, Rucker DD. On the practice of dichotomization of quantitative variables. Psychol Methods. 2002;7:19-40.
86. Altman DG. Categorizing continuous variables. In: Armitage P, Colton T, editors. Encyclopedia of biostatistics. 2nd ed. Chichester: John Wiley; 2005. p. 708-11.
87. Cohen J. The cost of dichotomization. Applied Psychological Measurement. 1983;7:249-53.
88. Zhao LP, Kolonel LN. Efficiency loss from categorizing quantitative exposures into qualitative exposures in case-control studies. American Journal of Epidemiology. 1992;136:464-74.
89. Cochran WG. The effectiveness of adjustment by subclassification in removing bias in observational studies. Biometrics. 1968;24:295-313.
90. Clayton D, Hills M. Models for dose-response (Chapter 25). Statistical Models in Epidemiology. Oxford: Oxford University Press; 1993. p. 249-60.
91. Cox DR. Note on grouping. J Am Stat Assoc. 1957;52:543-7.
92. Il'yasova D, Hertz-Picciotto I, Peters U, Berlin JA, Poole C. Choice of exposure scores for categorical regression in meta-analysis: a case study of a common problem. Cancer Causes Control. 2005;16:383-8.
93. Berglund A, Alfredsson L, Cassidy JD, Jensen I, Nygren A. The association between exposure to a rear-end collision and future neck or shoulder pain: a cohort study. J Clin Epidemiol. 2000;53:1089-94.
94. Slama R, Werwatz A. Controlling for continuous confounding factors: non- and semiparametric approaches. Rev Epidemiol Sante Publique 2005;53(Spec No 2):2S65-80.
95. Greenland S. Introduction to regression modelling (Chapter 21). In: Rothman KJ, Greenland S, editors. Modern epidemiology. 2nd ed: Lippincott Raven; 1998. p. 401-32.
96. Thompson WD. Statistical analysis of case-control studies. Epidemiol Rev. 1994;16:33-50.
97. Schlesselman JJ. Logistic regression for case-control studies (Chapter 8. 2). Case-control studies Design, conduct, analysis. New York, Oxford: Oxford University Press; 1982. p. 235-41.
98. Clayton D, Hills M. Choice and interpretation of models (Chapter 27). Statistical Models in Epidemiology. Oxford: Oxford University Press; 1993. p. 271-81.
99. Altman DG, Gore SM, Gardner MJ, Pocock SJ. Statistical guidelines for contributors to medical journals. Br Med J. 1983;286:1489-93.
100. International Committee of Medical Journal Editors (ICMJE).Uniform requirements for manuscripts submitted to biomedical journals. Electronic version updated February 2006, available at http://www.icmje.org. The New England Journal of Medicine 1997;336:309-15.
101. Mullner M, Matthews H, Altman DG. Reporting on statistical methods to adjust for confounding: a cross-sectional survey. AnnInternMed. 2002;136:122-6.
102. Olsen J, Basso O. Re: Residual confounding. American Journal of Epidemiology. 1999;149:290.
103. Hallan S, de Mutsert R, Carlsen S, Dekker FW, Aasarod K, Holmen J. Obesity, smoking, and physical inactivity as risk factors for CKD: are men more vulnerable? Am J Kidney Dis. 2006;47:396-405.
104. Gotzsche PC. Believability of relative risks and odds ratios in abstracts: cross sectional study. BMJ. 2006;333:231-4.
105. Szklo MF, Nieto J. Communicating Results of Epidemiologic Studies (Chapter 9). Epidemiology, Beyond the Basics. Sudbury, MA: Jones and Bartlett; 2000. p. 408-30.
106. Chandola T, Brunner E, Marmot M. Chronic stress at work and the metabolic syndrome: prospective study. BMJ. 2006;332:521-5.
107. Vach W, Blettner M. Biased estimation of the odds ratio in case-control studies due to the use of ad hoc methods of correcting for missing values for confounding variables. American Journal of Epidemiology. 1991;134:895-907.
108. Little RJ, Rubin DB. A taxonomy of missing-data methods (Chapter 1. 4.) (need to check). Statistical Analysis with Missing Data. New York: Wiley; 2002. p. 19-23.
109. Ware JH. Interpreting incomplete data in studies of diet and weight loss. The New England Journal of Medicine. 2003;348:2136-7.
110. Rubin DB. Inference and missing data. Biometrika. 1976;63:581-92.
111. Schafer JL. Analysis of Incomplete Multivariate Data. London: Chapman & Hall; 1997.
112. Lipsitz SR, Ibrahim JG, Chen MH, Peterson H. Non-ignorable missing covariates in generalized linear models. Stat Med. 1999;18:2435-48.
113. Rotnitzky A, Robins J. Analysis of semi-parametric regression models with non-ignorable non-response. Stat Med. 1997;16:81-102.
114. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York: John Wiley; 1987.
115. Barnard J, Meng XL. Applications of multiple imputation in medical studies: from AIDS to NHANES. Stat Methods Med Res. 1999;8:17-36.
116. Braitstein P, Brinkhof MW, Dabis F, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006;367:817-24.
117. Purandare N, Burns A, Daly KJ, et al. Cerebral emboli as a potential cause of Alzheimer's disease and vascular dementia: case-control study. BMJ. 2006;332:1119-24.
118. Steyn K, Gaziano TA, Bradshaw D, Laubscher R, Fourie J. Hypertension in South African adults: results from the Demographic and Health Survey, 1998. J Hypertens. 2001;19:1717-25.
119. Lohr SL. Design Effects (Chapter 7.5). Sampling: Design and Analysis. Pacific Grove: Duxbury Press.; 1999.
120. Dunn NR, Arscott A, Thorogood M. The relationship between use of oral contraceptives and myocardial infarction in young women with fatal outcome, compared to those who survive: results from the MICA case-control study. Contraception. 2001;63:65-9.
121. Rothman KJ, Greenland S. Basic Methods for Sensitivity Analysis and External Adjustment. In: Rothman KJ, Greenland S, editors. Modern epidemiology. 2nd ed: Lippincott Raven; 1998. p. 343-57.
122. Custer B, Longstreth WT, Jr., Phillips LE, Koepsell TD, Van Belle G. Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study. BMC Cancer. 2006;6:152.
123. Wakefield MA, Chaloupka FJ, Kaufman NJ, Orleans CT, Barker DC, Ruel EE. Effect of restrictions on smoking at home, at school, and in public places on teenage smoking: cross sectional study. BMJ. 2000;321:333-7.
124. Greenland S. The impact of prior distributions for uncontrolled confounding and response bias: a case study of the relation of wire codes and magnetic fields to childhood leukemia. Journal of the American Statistical Association. 2003;98:47-54.
125. Lash TL, Fink AK. Semi-automated sensitivity analysis to assess systematic errors in observational data. Epidemiology. 2003;14:451-8.
126. Phillips CV. Quantifying and reporting uncertainty from systematic errors. Epidemiology. 2003;14:459-66.
127. Cornfield J, Haenszel W, Hammond EC, Lilienfeld AM, Shimkin MB, Wynder EL. Smoking and lung cancer: recent evidence and a discussion of some questions. J Natl Cancer Inst. 1959;22:173-203.
128. Langholz B. Factors that explain the power line configuration wiring code-childhood leukemia association: what would they look like? Bioelectromagnetics 2001;Suppl 5:S19-31.
129. Eisner MD, Smith AK, Blanc PD. Bartenders' respiratory health after establishment of smoke-free bars and taverns. JAMA. 1998;280:1909-14.
130. Dunne MP, Martin NG, Bailey JM, et al. Participation bias in a sexuality survey: psychological and behavioural characteristics of responders and non-responders. International Journal of Epidemiology. 1997;26:844-54.
131. Schuz J, Kaatsch P, Kaletsch U, Meinert R, Michaelis J. Association of childhood cancer with factors related to pregnancy and birth. International Journal of Epidemiology. 1999;28:631-9.
132. Cnattingius S, Zack M, Ekbom A, Gunnarskog J, Linet M, Adami HO. Prenatal and neonatal risk factors for childhood myeloid leukemia. Cancer Epidemiol Biomarkers Prev. 1995;4:441-5.
133. Schuz J. Non-response bias as a likely cause of the association between young maternal age at the time of delivery and the risk of cancer in the offspring. Paediatr Perinat Epidemiol. 2003;17:106-12.
134. Slattery ML, Edwards SL, Caan BJ, Kerber RA, Potter JD. Response rates among control subjects in case-control studies. Annals of epidemiology. 1995;5:245-9.
135. Schulz KF, Grimes DA. Case-control studies: research in reverse. Lancet. 2002;359:431-4.
136. Olson SH, Voigt LF, Begg CB, Weiss NS. Reporting participation in case-control studies. Epidemiology. 2002;13:123-6.
137. Morton LM, Cahill J, Hartge P. Reporting participation in epidemiologic studies: a survey of practice. American Journal of Epidemiology. 2006;163:197-203.
138. Olson SH. Reported participation in case-control studies: changes over time. American Journal of Epidemiology. 2001;154:574-81.
139. Sandler DP. On revealing what we'd rather hide: the problem of describing study participation. Epidemiology. 2002;13:117
140. Hepworth SJ, Schoemaker MJ, Muir KR, Swerdlow AJ, van Tongeren MJ, McKinney PA. Mobile phone use and risk of glioma in adults: case-control study. BMJ. 2006;332:883-7.
141. Hay AD, Wilson A, Fahey T, Peters TJ. The duration of acute cough in pre-school children presenting to primary care: a prospective cohort study. Fam Pract. 2003;20:696-705.
142. Egger M, Juni P, Bartlett C. Value of flow diagrams in reports of randomized controlled trials. JAMA. 2001;285:1996-9.
143. Osella AR, Misciagna G, Guerra VM, et al. Hepatitis C virus (HCV) infection and liver-related mortality: a population-based cohort study in southern Italy. The Association for the Study of Liver Disease in Puglia. International Journal of Epidemiology. 2000;29:922-7.
144. Dales LG, Ury HK. An improper use of statistical significance testing in studying covariables. International Journal of Epidemiology. 1978;7:373-5.
145. Maldonado G, Greenland S. Simulation study of confounder-selection strategies. American Journal of Epidemiology. 1993;138:923-36.
146. Tanis BC, van den Bosch MA, Kemmeren JM, et al. Oral contraceptives and the risk of myocardial infarction. The New England Journal of Medicine. 2001;345:1787-93.
147. Rothman KJ, Greenland S. Precision and Validity in Epidemiologic Studies. In: Rothman KJ, Greenland S, editors. Modern epidemiology. 2nd ed: Lippincott Raven; 1998. p. 120-5.
148. Clark TG, Altman DG, De Stavola BL. Quantification of the completeness of follow-up. Lancet. 2002;359:1309-10.
149. Qiu C, Fratiglioni L, Karp A, Winblad B, Bellander T. Occupational exposure to electromagnetic fields and risk of Alzheimer's disease. Epidemiology. 2004;15:687-94.
150. Kengeya-Kayondo JF, Kamali A, Nunn AJ, Ruberantwari A, Wagner HU, Mulder DW. Incidence of HIV-1 infection in adults and sociodemographic characteristics of seroconverters in a rural population in Uganda: 1990-1994. International Journal of Epidemiology. 1996;25:1077-82.
151. Mastrangelo G, Fedeli U, Fadda E, et al. Increased risk of hepatocellular carcinoma and liver cirrhosis in vinyl chloride workers: synergistic effect of occupational exposure with alcohol intake. Environmental health perspectives. 2004;112:1188-92.
152. Salo PM, Arbes SJJr. , Sever M, et al. Exposure to Alternaria alternata in US homes is associated with asthma symptoms. The Journal of allergy and clinical immunology. 2006;118:892-8.
153. Pocock SJ, Clayton TC, Altman DG. Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls. Lancet. 2002;359:1686-9.
154. Sasieni P. A note on the presentation of matched case-control data. Stat Med. 1992;11:617-20.
155. Lee GM, Neutra RR, Hristova L, Yost M, Hiatt RA. A nested case-control study of residential and personal magnetic field measures and miscarriages. Epidemiology. 2002;13:21-31.
156. Tiihonen J, Walhbeck K, Lonnqvist J, et al. Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study. BMJ. 2006;333:224.
157. Christenfeld NJ, Sloan RP, Carroll D, Greenland S. Risk factors, confounding, and the illusion of statistical control. Psychosom Med. 2004;66:868-75.
158. Smith GD, Phillips A. Declaring independence: why we should be cautious. [published erratum appears in J Epidemiol Community Health 1991 Mar;45(1):88]. J Epidemiol Community Health. 1990;44:257-8.
159. Greenland S, Neutra R. Control of confounding in the assessment of medical technology. International Journal of Epidemiology. 1980;9:361-7.
160. Robins JM. Data, design, and background knowledge in etiologic inference. Epidemiology. 2001;12:313-20.
161. Sagiv SK, Tolbert PE, Altshul LM, Korrick SA. Organochlorine exposures during pregnancy and infant size at birth. Epidemiology. 2007;18:120-9.
162. World Health Organization. Body Mass Index (BMI). Accessed at: http://www.euro.who.int/nutrition/20030507_1.
163. Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet. 2003;362:419-27.
164. Hill AB. The Environment and Disease: Association or Causation? Proc R Soc Med. 1965;58:295-300.
165. Vineis P. Causality in epidemiology. Soz Praventivmed. 2003;48:80-7.
166. Empana JP, Ducimetiere P, Arveiler D, et al. Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. Eur Heart J. 2003;24:1903-11.
167. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet. 1999;353:1547-57.
168. Cambien F, Chretien JM, Ducimetiere P, Guize L, Richard JL. Is the relationship between blood pressure and cardiovascular risk dependent on body mass index? American Journal of Epidemiology. 1985;122:434-42.
169. Hosmer DW, Taber S, Lemeshow S. The importance of assessing the fit of logistic regression models: a case study. American journal of public health. 1991;81:1630-5.
170. Tibshirani R. A plain man's guide to the proportional hazards model. Clin Invest Med. 1982;5:63-8.
171. Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. American journal of public health. 1998;88:15-9.
172. Uter W, Pfahlberg A. The application of methods to quantify attributable risk in medical practice. Stat Methods Med Res. 2001;10:231-7.
173. Schwartz LM, Woloshin S, Dvorin EL, Welch HG. Ratio measures in leading medical journals: structured review of accessibility of underlying absolute risks. BMJ. 2006;333:1428
174. Nakayama T, Zaman MM, Tanaka H. Reporting of attributable and relative risks, 1966-97. Lancet. 1998;351:1179.
175. Cornfield J. A method of estimating comparative rates from clinical data; applications to cancer of the lung, breast, and cervix. J Natl Cancer Inst. 1951;11:1269-75.
176. Pearce N. What does the odds ratio estimate in a case-control study? International Journal of Epidemiology. 1993;22:1189-92.
177. Rothman KJ, Greenland S. Measures of Disease Frequency. In: Rothman KJ, Greenland S, editors. Modern epidemiology. 2nd ed: Lippincott Raven; 1998. p. 44-5.
178. Doll R, Hill AB. The mortality of doctors in relation to their smoking habits: a preliminary report. 1954. BMJ. 328:1529-33, 2004; discussion 33.
179. Ezzati M, Lopez AD. Estimates of global mortality attributable to smoking in 2000. Lancet. 2003;362:847-52.
180. Greenland S. Applications of Stratified Analysis Methods. In: Rothman KJ, Greenland S, editors. Modern Epidemiology. 2nd ed: Lippincott Raven; 1998. p. 295-7.
181. Rose G. Sick individuals and sick populations. International Journal of Epidemiology. 2001;30:427-32 discussion 33-4.
182. Vandenbroucke JP, Koster T, Briet E, Reitsma PH, Bertina RM, Rosendaal FR. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet. 1994;344:1453-7.
183. Botto LD, Khoury MJ. Commentary: facing the challenge of gene-environment interaction: the two-by-four table and beyond. American Journal of Epidemiology. 2001;153:1016-20.
184. Wei L, MacDonald TM, Walker BR. Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Annals of Internal Medicine. 2004;141:764-70.
185. Martinelli I, Taioli E, Battaglioli T, et al. Risk of venous thromboembolism after air travel: interaction with thrombophilia and oral contraceptives. Arch Intern Med. 2003;163:2771-4.
186. Kyzas PA, Loizou KT, Ioannidis JP. Selective reporting biases in cancer prognostic factor studies. J Natl Cancer Inst. 2005;97:1043-55.
187. Rothman KJ, Greenland S, Walker AM. Concepts of interaction. American Journal of Epidemiology. 1980;112:467-70.
188. Saracci R. Interaction and synergism. American Journal of Epidemiology. 1980;112:465-6.
189. Rothman KJ. Epidemiology. An introduction. Oxford: Oxford University Press; 2002. p. 168-80.
190. Rothman KJ. Interactions Between Causes. Modern epidemiology. Boston: Little Brown,; 1986. p. 311-26.
191. Hess DR. How to write an effective discussion. Respir Care. 2004;49:1238-41.
192. Horton R. The hidden research paper. JAMA. 2002;287:2775-8.
193. Horton R. The rhetoric of research. BMJ. 1995;310:985-7.
194. Docherty M, Smith R. The case for structuring the discussion of scientific papers. BMJ. 1999;318:1224-5.
195. Perneger TV, Hudelson PM. Writing a research article: advice to beginners. Int J Qual Health Care. 2004;16:191-2.
196. Annals of Internal Medicine. Information for authors. [cited; Available from: http://www.annals.org/shared/author_info. shtml#manuscriptpreparation
197. Maldonado G, Poole C. More research is needed. Annals of epidemiology. 1999;9:17-8.
198. Phillips CV. The economics of 'more research is needed'. International Journal of Epidemiology. 2001;30:771-6.
199. Winkleby MA, Kraemer HC, Ahn DK, Varady AN. Ethnic and socioeconomic differences in cardiovascular disease risk factors: findings for women from the Third National Health and Nutrition Examination Survey, 1988-1994. JAMA. 1998;280:356-62.
200. Galuska DA, Will JC, Serdula MK, Ford ES. Are health care professionals advising obese patients to lose weight? JAMA. 1999;282:1576-8.
201. Spearman C. The proof and measurement of association between two things. Am J Psychol. 1904;15:72-101.
202. Fuller WA, Hidiroglou MA. Regression estimates after correcting for attenuation. J Am Stat Assoc. 1978;73:99-104.
203. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective
204. Phillips AN, Smith GD. How independent are "independent" effects? Relative risk estimation when correlated exposures are measured imprecisely. J Clin Epidemiol. 1991;44:1223-31.
205. Phillips AN, Smith GD. Bias in relative odds estimation owing to imprecise measurement of correlated exposures. Stat Med. 1992;11:953-61.
206. Greenland S. The effect of misclassification in the presence of covariates. American Journal of Epidemiology. 1980;112:564-9.
207. Poole C, Peters U, Il'yasova D, Arab L. Commentary: This study failed? International Journal of Epidemiology. 2003;32:534-5.
208. Kaufman JS, Cooper RS, McGee DL. Socioeconomic status and health in blacks and whites: the problem of residual confounding and the resiliency of race. Epidemiology. 1997;8:621-8.
209. Greenland S. Randomization, statistics, and causal inference. Epidemiology. 1990;1:421-9.
210. Taubes G. Epidemiology faces its limits. Science. 1995;269:164-9.
211. Temple R. Meta-analysis and epidemiologic studies in drug development and postmarketing surveillance. JAMA. 1999;281:841-4.
212. Greenberg RS, Shuster JLJr. Epidemiology of cancer in children. Epidemiol Rev. 1985;7:22-48.
213. Kushi LH, Mink PJ, Folsom AR, et al. Prospective study of diet and ovarian cancer. American Journal of Epidemiology. 1999;149:21-31.
214. Kemmeren JM, Algra A, Meijers JC, et al. Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation: a randomized trial. Blood. 2004;103:927-33.
215. Egger M, May M, Chene G, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002;360:119-29.
216. Campbell DT. Factors relevant to the validity of experiments in social settings. Psychol Bull. 1957;54:297-312.
217. Justice AC, Covinsky KE, Berlin JA. Assessing the generalizability of prognostic information. Annals of Internal Medicine. 1999;130:515-24.
218. Krimsky S, Rothenberg LS. Conflict of interest policies in science and medical journals: editorial practices and author disclosures. Sci Eng Ethics 2001;7:205-18.
219. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA. 2003;289:454-65.
220. Davidson RA. Source of funding and outcome of clinical trials. J Gen Intern Med. 1986;1:155-8.
221. Stelfox HT, Chua G, O'Rourke K, Detsky AS. Conflict of interest in the debate over calcium-channel antagonists. The New England Journal of Medicine. 1998;338:101-6.
222. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ. 2003;326:1167-70.
223. Als-Nielsen B, Chen W, Gluud C, Kjaergard LL. Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? JAMA. 2003;290:921-8.
224. Barnes DE, Bero LA. Industry-funded research and conflict of interest: an analysis of research sponsored by the tobacco industry through the Center for Indoor Air Research. J Health Polit Policy Law. 1996;21:515-42.
225. Barnes DE, Bero LA. Why review articles on the health effects of passive smoking reach different conclusions. JAMA. 1998;279:1566-70.
226. Glantz SA, Barnes DE, Bero L, Hanauer P, Slade J. Looking through a keyhole at the tobacco industry. The Brown and Williamson documents. JAMA. 1995;274:219-24.
227. Huss A, Egger M, Hug K, Huwiler-Muntener K, Roosli M. Source of funding and results of studies of health effects of mobile phone use: systematic review of experimental studies. Environmental health perspectives. 2007;115:1-4.
228. Safer DJ. Design and reporting modifications in industry-sponsored comparative psychopharmacology trials. J Nerv Ment Dis. 2002;190:583-92.
229. Aspinall RL, Goodman NW. Denial of effective treatment and poor quality of clinical information in placebo controlled trials of ondansetron for postoperative nausea and vomiting: a review of published trials. BMJ. 1995;311:844-6.
230. Chan AW, Hrobjartsson A, Haahr MT, Gotzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA. 2004;291:2457-65.
231. Melander H, Ahlqvist-Rastad J, Meijer G, Beermann B. Evidence b(i)ased medicine-selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. BMJ. 2003;326:1171-3.
232. Scherer RW, Langenberg P, von Elm E. Full publication of results initially presented in abstracts. Cochrane Database of Systematic Reviews. 2007;2. No. MR000005.
233. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet. 2001;357:1191-4.
234. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008-12.
235. Altman DG, Schulz KF, Moher D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Annals of Internal Medicine. 2001;134:663-94.
236. Moher D. CONSORT: an evolving tool to help improve the quality of reports of randomized controlled trials. Consolidated Standards of Reporting Trials. JAMA. 1998;279:1489-91.
237. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA. 1996;276:637-9.